|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Rational use of oral contraceptives in the perimenopausal woman. |
| JOURNAL OF REPRODUCTIVE MEDICINE. 1993 Dec;38(12 Suppl):1036-40. |
| Few family planning specialists are examining the potential bone-protective effects of oral contraceptives (OCs) in |
| premenopausal and perimenopausal women. Osteoporosis is a major public health problem worldwide, as reflected |
| in its associated morbidity and mortality and economic impact. For example, more than 25 million people in the US |
| have osteoporosis, which costs society $7-10 billion each year. These costs are largely due to the more than 1.3 |
| million fractures each year. The 250,000 hip fractures are responsible for the highest personal and societal cost. 12- |
| 20% of women with a hip fracture die within 2-3 months of the fracture. At least 50% need assistance with daily |
| activities. Clinicians and public health specialists are not putting their energy into developing strategies that may |
| preserve bone density in the premenopausal and perimenopausal years. More emphasis is needed on such |
| strategies, since menopause is the time when bone loss accelerates. Clinicians do stress hormone replacement as |
| a preventive therapy, but this is restricted to postmenopausal women. Extensive research and development of lower- |
| dose OCs and data on appropriate screening of women with risk factors (e.g., smoking, obesity, and hypertension) |
| demonstrate that healthy, nonsmoking women can use OCs safely and effectively throughout most of their |
| reproductive years. Perhaps OC use can provide women the noncontraceptive benefit of maintenance and build up of |
| bone mass up to menopause. (PubHealth.info Document ID: CONT2T 4583-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Rational use of oral contraceptives in the perimenopausal |
| woman.", is(are) Connell EB. The source of this article is "JOURNAL OF REPRODUCTIVE MEDICINE. 1993 |
| Dec;38(12 Suppl):1036-40.". This article was published in 1993 in English language(s). (PubHealth.info® Document |
| ID: CONT2T 4583-06. All rights reserved with PubHealth.info) PIN: 9583 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
